JB Chemicals non-executive director Sanjay Nayar steps down
Mumbai: J. B. Chemicals & Pharmaceuticals Ltd. has recently announced that Mr. Sanjay Nayar, non-executive director, has resigned as a director of the company effective January 25, 2022.
"This is to inform you that Mr. Sanjay Nayar, non-executive director, has resigned as a director of J. B. Chemicals & Pharmaceuticals Ltd. effective January 25, 2022 due to other commitments," the company said in a BSE filing.
" Sanjay Nayar is Chairman of KKR India. He joined KKR in 2009 and was Partner & CEO of KKR India until January 2021. Prior to joining KKR, he served as CEO of Citigroup's Indian and South Asian operations," reads details of Nayar on JB Chemicals' official site.
He was a member of Citigroup's Management Committee and Asia Executive Operating Committee from 2002 – 2009. Mr. Nayar also served Citibank/Citigroup for 25 years in various positions in India, UK, and USA. Mr. Nayar is a member of the Board of US-India Strategic Partnership Forum (USISPF), the Governing Board of Indian School of Business (ISB), is an Executive Member of CII PE/VC Committee, and as recently as November 2020 tenured from SEBI's NISM Board of Governors after six years. He has obtained a B.Sc. (Hons) from the Delhi College of Engineering and an MBA (Finance) from the Indian Institute of Management, Ahmedabad.
Read also: JB Chemicals to strike Rs 628 crore deal with Sanzyme for probiotic, reproductive brands
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.